Reata Pharmaceuticals, Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
26
Ending by 2030
Aug 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 28, 2027The maintenance fee for Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring (US 9,090,574) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
- 1 fee due Feb 11, 2027The maintenance fee for Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17 (US 9,102,681) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due Mar 3, 2027The maintenance fee for C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof (US 10,398,711) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 1 fee due Apr 13, 2027The maintenance fee for Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-Me (US 9,155,721) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
- 3 fees due May 3 to 28, 2027 · next May 3
- 1 fee due Jun 10, 2027The maintenance fee for C17-Alkanediyl and Alkenediyl Derivatives of Oleanolic Acid and Methods of Use Thereof (US 10,501,489) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 2 fees due Jul 12 to 16, 2027 · next Jul 12
- 3 fees due Aug 2 to 27, 2027 · next Aug 2
- 3 fees due Sep 5 to 22, 2027 · next Sep 5
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
- 1 term has ended since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,309,601 | Novel Forms of Cddo Methyl Ester In force · High confidence | In force | High confidence | |
| US 8,633,243 | Novel Forms of Cddo Methyl Ester In force · High confidence | In force | High confidence | |
| US 8,455,544 | Synthetic Triterpenoids and Methods of Use in the Treatment of Disease In force · Medium confidence | In force | Medium confidence | |
| US 7,943,778 | Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives In force · High confidence | In force | High confidence | |
| US 8,394,967 | Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives In force · High confidence | In force | High confidence | |
| US 8,440,820 | Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring In force · High confidence | In force | High confidence | |
| US 8,440,854 | Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17 In force · High confidence | In force | High confidence | |
| US 9,090,574 | Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring In force · Medium confidence | In force | Medium confidence | |
| US 9,102,681 | Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17 In force · High confidence | In force | High confidence | |
| US 9,233,998 | Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use In force · High confidence | In force | High confidence |
Also on record, not counted in the 65: 1 patent in force now held by others · 5 lapsed for an unpaid fee · 2 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 pending · 9 abandoned · 1 no status recorded